The development of membranous lupus nephritis during treatment with mycophenolate mofetil for proliferative renal disease

被引:4
|
作者
Dalton, Kristen [1 ]
Smith, Maxwell [2 ,3 ]
Thurman, Joshua M. [1 ]
机构
[1] Univ Colorado Denver, Sch Med, Dept Med, Denver, CO 80204 USA
[2] Univ Colorado Denver, Sch Med, Dept Pathol, Aurora, CO USA
[3] Univ Colorado Denver, Sch Med, Dept Med, Aurora, CO USA
来源
CLINICAL KIDNEY JOURNAL | 2010年 / 3卷 / 04期
关键词
membranous lupus nephritis; mycophenolate mofetil; transformation;
D O I
10.1093/ndtplus/sfq046
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The transformation of lupus nephritis from one histologic pattern to another is well described. We report a case of a patient who initially presented with diffuse proliferative glomerulonephritis and was treated with prednisone and mycophenolate mofetil (MMF). She initially responded well to therapy, but later developed high-grade proteinuria while still on MMF and low-dose steroids. A repeat biopsy performed after the increase in proteinuria demonstrated that she had focal proliferative disease but that she had also developed membranous lupus nephritis. Our case is unique in that we report a patient who developed membranous lupus nephritis while receiving MMF.
引用
收藏
页码:346 / 348
页数:3
相关论文
共 50 条
  • [41] Cyclophosphamide versus mycophenolate mofetil for initial treatment of lupus nephritis
    Du, Xin
    Wan, Xin
    Cao, Changchun
    [J]. KIDNEY INTERNATIONAL, 2013, 83 (05) : 968 - 969
  • [42] Mycophenolate Mofetil for Induction Treatment Of lupus Nephritis, The evidence is sufficient?
    Julia Cumpa-Davila, Maria
    [J]. REVISTA DEL CUERPO MEDICO DEL HOSPITAL NACIONAL ALMANZOR AGUINAGA ASENJO, 2012, 5 (02): : 22 - 24
  • [43] THE EFFICACY OF MYCOPHENOLATE MOFETIL ON TREATMENT OF NEW CASES OF LUPUS NEPHRITIS
    Sanadgol, Houshang
    Najafi, Iraj
    Majalan, Nader Nouri
    Tabatabai, Mohamad Taghi
    Zakeri, Zahra
    [J]. NEPHROLOGY, 2005, 10 : A167 - A167
  • [44] The effective use of Mycophenolate mofetil in the treatment of lupus nephritis.
    Kingdon, EJ
    Psimenou, E
    Sweny, P
    Burns, A
    [J]. KIDNEY INTERNATIONAL, 1999, 55 (06) : 2563 - 2563
  • [45] Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy
    Nawata, Takashi
    Kubo, Makoto
    Fujii, Shohei
    Shiragami, Kosaku
    Ikegami, Tadayoshi
    Kobayashi, Shigeki
    Hisano, Satoshi
    Yano, Masafumi
    [J]. INTERNAL MEDICINE, 2018, 57 (14) : 2067 - 2070
  • [46] Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome
    Yap, Desmond Y. H.
    Yu, Xueqing
    Chen, Xiang-Mei
    Lu, Fuming
    Chen, Nan
    Li, Xue-Wang
    Tang, Colin So
    Chan, Tak Mao
    [J]. NEPHROLOGY, 2012, 17 (04) : 352 - 357
  • [47] Induction Therapy for Pediatric Focal Proliferative Lupus Nephritis: Cyclophosphamide Versus Mycophenolate Mofetil
    Lau, Keith K.
    Ault, Bettina H.
    Jones, Deborah P.
    Butani, Lavjay
    [J]. JOURNAL OF PEDIATRIC HEALTH CARE, 2008, 22 (05) : 282 - 288
  • [48] Mycophenolate mofetil or intravenous cyclophosphamide in lupus nephritis
    Killen, JP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (07): : 764 - 765
  • [49] Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
    Ginzler, EM
    Dooley, MA
    Aranow, C
    Kim, MY
    Buyon, J
    Merrill, JT
    Petri, M
    Gilkeson, GS
    Wallace, DJ
    Weisman, MH
    Appel, GB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (21): : 2219 - 2228
  • [50] Treatment with mycophenolate mofetil attenuates the development of Heymann nephritis
    Luca, ME
    Paul, LC
    van der Wal, AM
    Bruijn, JA
    de Heer, E
    [J]. EXPERIMENTAL NEPHROLOGY, 2000, 8 (02): : 77 - 83